ExerciseRx app for people with axial spondyloarthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates whether using the ExerciseRx mobile app, which provides guided exercises and weekly step goals, is practical and beneficial for people with axial spondyloarthritis. Participants perform 20–30 minute guided exercise sessions four times per week and aim for personalized activity goals while wearing a Fitbit. Outcomes are compared to a usual-care group to see changes in symptoms, physical function, and disease activity. The study requires English-speaking adults with axSpA who are insufficiently active and have internet access throughout the study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of axial spondyloarthritis by a rheumatologist
* English speaking
* Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week)
* Willing to wear a Fitbit for the study duration
* Willing to have or create a Google account and download the Google Health app (previously known as the Fitbit app)

Exclusion Criteria:

* Currently pregnant
* International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period
* Recent or planned surgery that may affect ability to engage in physical activity
* Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons
* Unable to walk safely without difficulty, or is a fall risk (i.e., 3+ falls in past 6 months)
* History of a fall resulting in a fracture or head injury in the past 6 months
* Cardiovascular contraindicators for physical activity, or history of cardiovascular problems that may be exacerbated by physical activity, as defined by their rheumatologist
* Diabetes causing hypoglycemia following physical activity

Where it's running

• Harborview Medical Center
  Seattle, Washington, United States Recruiting
• University of Washington
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Rachael Stovall, MD — University of Washington
• Study coordinator: Joy Chan
• Email: joychan@uw.edu
• Phone: 206-744-3626

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surface topography and spine damage in radiographic axial spondyloarthritis

  This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.

  Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07855393

• RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms

  A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07836374

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Bimekizumab by IV infusion versus subcutaneous injection for adults with psoriatic arthritis or axial spondyloarthritis

  This trial tests whether bimekizumab given by intravenous (IV) infusion behaves the same in the body as the usual subcutaneous injection in adults with psoriatic arthritis or axial spondyloarthritis.

  Recruiting at 65 sites Phase 1 UCB Pharma · Peoria, Arizona and 64 other locations · NCT07290036

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• Assessing Bimekizumab Levels in Breast Milk of Nursing Mothers

  This study tests how much of the medication bimekizumab is found in the breast milk of mothers who have been using it for at least 12 weeks after giving birth to see if it's safe for their babies.

  Recruiting at 14 sites Phase 1 UCB Pharma · Santa Monica, California and 13 other locations · NCT06888193

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.